TCL Archive Three Bomb Threats At NIH In One Week result In Evacuations, Investigations August 2, 1996
TCL Archive Abraxane-Gemcitabine Combination Extends Overall Survival in Phase III Trial January 31, 2014
TCL Archive Did Iressa Data Merit Approval? Experts Discuss Implications For Drug Development, Lung Cancer Treatment, Reimbursement (12-page issue). May 9, 2003
TCL Archive NSABP Submits Appeal To NIH To Reverse Cancellation Of P-4 Chemoprevention Trial. August 10, 2007